DiscoverIllumina Genomics PodcastctDNA-guided treatment in colorectal cancer
ctDNA-guided treatment in colorectal cancer

ctDNA-guided treatment in colorectal cancer

Update: 2024-04-10
Share

Description

Jeanne Tie, MD, discusses the DYNAMIC trial and areas of unmet needs for minimal residual disease (MRD) to become the standard of care for patients with colorectal cancer. The DYNAMIC trial showed that a ctDNA-guided approach reduces the use of adjuvant treatment in patients with stage II colon cancer without compromising their clinical outcome. Jeanne Tie is a medical oncologist and professor at Peter MacCallum Cancer Centre.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

ctDNA-guided treatment in colorectal cancer

ctDNA-guided treatment in colorectal cancer

Illumina Genomics Podcast